Acadia Pharmaceuticals Inc. | Mid-cap | Healthcare
$20.88
-0.33%
| Acadia Stock Comparison:
Acadia vs VertexAcadia vs RegeneronAcadia vs Blueprint MedicinesAcadia vs Roivant SciencesAcadia vs Bio-TechneAcadia vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 957.8M
Gross Profit 876.0M 91.46%
Operating Income 84.3M 8.80%
Net Income 226.5M 23.64%
EPS (Diluted) $1.36

Balance Sheet Metrics

Total Assets 1.2B
Total Liabilities 455.0M
Shareholders Equity 732.8M
Debt to Equity 0.62

Cash Flow Metrics

Operating Cash Flow 259.1M
Free Cash Flow 157.2M

Revenue & Profitability Trend

Acadia Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue957.8M726.4M517.2M484.1M441.8M
Cost of Goods Sold81.8M41.6M10.2M19.1M20.6M
Gross Profit876.0M684.8M507.1M465.0M421.2M
Operating Expenses791.7M758.2M730.7M635.4M707.8M
Operating Income84.3M-73.4M-223.6M-170.4M-286.6M
Pre-tax Income258.1M-51.0M-213.4M-167.5M-281.0M
Income Tax31.6M10.2M2.5M351.0K611.0K
Net Income226.5M-61.3M-216.0M-167.9M-281.6M
EPS (Diluted)$1.36-$0.37-$1.34-$1.05-$1.79

Income Statement Trend

Acadia Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets938.3M616.1M507.9M617.8M717.6M
Non-Current Assets249.4M132.8M79.9M82.3M65.0M
Total Assets1.2B749.0M587.8M700.1M782.6M
Liabilities
Current Liabilities394.9M254.3M125.6M96.1M106.0M
Non-Current Liabilities60.1M62.9M61.8M63.2M49.6M
Total Liabilities455.0M317.2M187.4M159.2M155.6M
Equity
Total Shareholders Equity732.8M431.8M400.4M540.9M627.0M

Balance Sheet Composition

Acadia Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income226.5M-61.3M-216.0M-167.9M-281.6M
Operating Cash Flow259.1M-46.7M-134.6M-119.1M-154.4M
Investing Activities
Capital Expenditures-523.0K-50.0K0-1.1M-7.6M
Investing Cash Flow-30.5M72.0M73.2M-71.1M192.5M
Financing Activities
Dividends Paid-----
Financing Cash Flow6.8M25.1M8.2M18.2M81.0M
Free Cash Flow157.2M-23.3M-114.0M-126.8M-143.8M

Cash Flow Trend

Acadia Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 16.41
Forward P/E 27.41
Price to Book 4.91
Price to Sales 3.78
PEG Ratio 27.41

Profitability Ratios

Profit Margin 22.97%
Operating Margin 7.90%
Return on Equity 37.24%
Return on Assets 5.56%

Financial Health

Current Ratio 2.88
Debt to Equity 7.32
Beta 0.65

Per Share Data

EPS (TTM) $1.37
Book Value per Share $4.58
Revenue per Share $5.99

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
acad3.8B16.414.9137.24%22.97%7.32
Vertex 114.1B32.826.92-5.64%-8.91%10.00
Regeneron 55.3B13.021.8415.96%31.94%9.20
Blueprint Medicines 8.3B-120.0024.19-47.71%-27.70%208.50
Roivant Sciences 7.8B1.951.71-12.54%96.86%1.93
Bio-Techne 7.9B60.873.926.53%10.89%20.99

Financial data is updated regularly. All figures are in the company's reporting currency.